PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
18.78%
Growth of 18.78% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
3.89%
Cost growth exceeding 1.5x Healthcare median of 0.15%. Jim Chanos would check for structural cost disadvantages.
49.59%
Growth of 49.59% versus flat Healthcare gross profit. Walter Schloss would verify quality.
25.94%
Margin change of 25.94% versus flat Healthcare margins. Walter Schloss would verify quality.
4.80%
R&D change of 4.80% versus flat Healthcare spending. Walter Schloss would verify adequacy.
10.60%
G&A change of 10.60% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
-24.93%
Marketing expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
-53.22%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-0.97%
Operating expenses reduction while Healthcare median is 5.04%. Seth Klarman would investigate advantages.
2.07%
Total costs growth below 50% of Healthcare median of 5.98%. Joel Greenblatt would investigate efficiency.
61.86%
Interest expense change of 61.86% versus flat Healthcare costs. Walter Schloss would verify control.
5.29%
D&A growth exceeding 1.5x Healthcare median of 0.63%. Jim Chanos would check for overinvestment.
262.69%
EBITDA change of 262.69% versus flat Healthcare. Walter Schloss would verify quality.
-20.53%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
190.40%
Income change of 190.40% versus flat Healthcare. Walter Schloss would verify quality.
176.11%
Margin change of 176.11% versus flat Healthcare. Walter Schloss would verify quality.
10539.46%
Other expenses growth while Healthcare reduces costs. Peter Lynch would examine differences.
211.19%
Pre-tax income growth while Healthcare declines. Peter Lynch would examine advantages.
193.61%
Margin change of 193.61% versus flat Healthcare. Walter Schloss would verify quality.
363.97%
Tax expense change of 363.97% versus flat Healthcare. Walter Schloss would verify strategy.
171.27%
Income change of 171.27% versus flat Healthcare. Walter Schloss would verify quality.
160.00%
Margin change of 160.00% versus flat Healthcare. Walter Schloss would verify quality.
162.90%
EPS growth exceeding 1.5x Healthcare median of 3.88%. Joel Greenblatt would investigate advantages.
162.90%
Diluted EPS growth exceeding 1.5x Healthcare median of 4.00%. Joel Greenblatt would investigate advantages.
2.26%
Share count reduction below 50% of Healthcare median of 0.28%. Jim Chanos would check for issues.
2.43%
Diluted share reduction below 50% of Healthcare median of 0.27%. Jim Chanos would check for issues.